Establishing Appropriate Antimicrobial Use Across One Health

Global health authorities increasingly recognize antimicrobial resistance as an urgent intersectoral threat that connects human medicine, veterinary care, and ecosystems. Consequently, achieving appropriate antimicrobial use serves as the vital foundation of modern clinical and agricultural stewardship programs. However, health professionals and livestock producers historically lacked a shared, operational understanding of what constitutes judicious practice in everyday settings. While high-level declarations urge global reduction, real-world prescribing involves delicate balances between patient survival, diagnostic uncertainty, and socio-economic pressures. Recent qualitative investigations reveal that definitions must reflect operational realities rather than theoretical ideals alone. Therefore, building a unified One Health consensus remains crucial to harmonize prescribing quality across clinical and agricultural sectors. A pragmatic definition must consider indication, timing, drug choice, dosage, and duration while respecting contextual limitations. Without a clear consensus, health systems cannot accurately audit prescribing behaviors or benchmark clinical performance. Furthermore, fragmented definitions impede cross-sectoral collaboration between human doctors and veterinary practitioners. Establishing common terminology allows multidisciplinary teams to coordinate surveillance, design joint interventions, and protect existing antimicrobial reserves effectively.

Structural and Economic Pressures in Clinical Practice

In outpatient and hospital settings, daily structural constraints heavily undermine rational prescribing intentions. Physicians routinely encounter severe time limitations, crowded consultation rooms, and significant delays in microbiological diagnostic testing. Consequently, clinicians frequently initiate broad-spectrum empiric antimicrobial therapy to prevent patient deterioration while awaiting laboratory confirmation. Furthermore, health systems often lack accessible pathways for rapid patient review and treatment de-escalation. When follow-up consultations remain unaffordable or logistically difficult for patients, prescribers face tremendous pressure to provide definitive therapy during a single encounter. Conflicting patient expectations also complicate antimicrobial decision-making across primary care facilities. Many patients expect immediate pharmaceutical relief, mistakenly believing that antibiotics resolve uncomplicated viral infections. When clinicians face extreme time scarcity, patient education becomes difficult, making antibiotic prescribing the path of least resistance. Additionally, defensive medical practice encourages overtreatment in settings where diagnostic ambiguity creates potential liability concerns. Overcoming these entrenched systemic barriers requires fundamental administrative support rather than individual clinician blame. Providing rapid point-of-care testing, protected consultation time, and institutional follow-up mechanisms will empower clinicians to practice evidence-based prescribing safely.

Livestock Realities and Agricultural Stewardship Dilemmas

Just as human clinicians navigate severe operational hurdles, veterinary professionals and livestock producers face significant economic and regulatory tensions. In commercial animal husbandry, shifting consumer preferences generate contradictory market pressures. For instance, consumers increasingly demand free-range and antibiotic-free meat, yet they still expect low grocery prices and flawless animal welfare. This commercial conflict creates intense dilemmas for livestock managers when managing contagious bacterial outbreaks. Producers must act quickly to prevent widespread herd mortality and devastating financial collapse. However, existing regulations governing off-label veterinary antimicrobial therapy often restrict therapeutic choices, forcing producers into difficult treatment compromises. Furthermore, structural differences between small family farms and corporate agro-enterprises influence prescribing patterns profoundly. Large enterprises frequently employ dedicated veterinary staff and maintain advanced biosecurity infrastructure. In contrast, smallholders often lack regular veterinary oversight and depend on informal retail outlets for animal treatments. Consequently, economic survival drives therapeutic choices among small livestock operations. Policymakers must recognize that sustainable stewardship requires viable financial alternatives, accessible veterinary expertise, and biosecurity support rather than simple therapeutic bans.

Information Deficits and Interprofessional Communication Gaps

Effective antimicrobial stewardship relies heavily on transparent communication and comprehensive stakeholder education. Nevertheless, recent qualitative evidence highlights persistent educational gaps among livestock producers, patients, and healthcare providers. Many agricultural operators report receiving minimal formal education regarding responsible antimicrobial administration, withdrawal periods, and resistance transmission risks. Similarly, public understanding regarding the biological differences between viral and bacterial infections remains inadequate across many communities. Patients frequently request antibiotics for seasonal colds, viral sore throats, and self-limiting febrile episodes. Furthermore, public health campaigns often rely on dense clinical terminology that fails to connect with non-academic audiences. Communication channels such as local agricultural cooperatives, primary schools, and community health networks remain underutilized for stewardship messaging. In clinical consultations, physicians rarely have access to clear educational tools to support shared decision-making dialogues with hesitant patients. Consequently, doctors struggle to explain treatment withholding without making patients feel dismissed. Dismantling these educational barriers requires co-designing tailored educational initiatives with community leaders, primary doctors, and farming representatives. Consistent, accessible messaging builds mutual trust and encourages responsible antimicrobial choices.

Implications for Indian Healthcare and Delphi Consensus

These structural, economic, and informational hurdles carry profound relevance for India’s ongoing containment of antimicrobial resistance. India currently contends with some of the highest global resistance rates against critical reserve antimicrobials across both community and tertiary care settings. In response, the Government of India launched the National Action Plan on Antimicrobial Resistance (NAP-AMR) 2.0 to coordinate multi-sectoral containment strategies. Furthermore, the Indian Council of Medical Research published comprehensive stewardship guidelines to enhance prescribing quality across domestic healthcare facilities. However, translating central policies into grassroots clinical practice remains challenging due to diagnostic cost barriers, busy clinics, and over-the-counter medicine access. Similar structural deficits in the veterinary sector perpetuate informal antibiotic use in livestock production. Therefore, international researchers are deploying formal Delphi consensus methods to establish practical, context-specific definitions of appropriate use. By convening physicians, veterinarians, microbiologists, and agricultural stakeholders through iterative survey rounds, this Delphi process establishes realistic, tiered benchmarks. These consensus metrics will enable Indian institutions to audit clinical prescriptions fairly, support veterinary biosecurity, and safeguard life-saving antimicrobial therapies across all sectors.

Frequently Asked Questions

What does a One Health perspective add to antibiotic stewardship?

A One Health perspective recognizes that human, animal, and environmental health are fundamentally interconnected. Pathogens and resistance genes move continuously between livestock, agricultural soil, water bodies, and human communities. Consequently, limiting antimicrobial stewardship solely to human hospitals cannot resolve antimicrobial resistance. By uniting veterinarians, agricultural producers, ecologists, and physicians, One Health creates cohesive cross-sectoral interventions. This integrated approach ensures that decisions in one sector do not inadvertently accelerate resistance or compromise treatment efficacy elsewhere.

How do economic barriers impede appropriate antimicrobial use in livestock?

Livestock producers operate in highly competitive commercial environments where infectious outbreaks can trigger immediate bankruptcy. Because biosecurity infrastructure, diagnostic testing, and private veterinary consultations demand substantial capital, smallholder farmers often rely on affordable over-the-counter antimicrobials to protect their animals. Furthermore, consumer demand for inexpensive animal protein conflicts with strict antibiotic-free production mandates. Without financial safety nets, insurance mechanisms, or government-subsidized veterinary services, farmers face strong economic pressures to administer antimicrobials prophylactically to safeguard their livelihood.

Why must clinical guidelines account for review appointment access?

Standard antimicrobial stewardship guidelines instruct physicians to prescribe targeted therapies and re-evaluate clinical progress within 48 to 72 hours. However, in resource-constrained outpatient settings, many patients cannot attend follow-up consultations due to transportation barriers, work obligations, or acute poverty. Consequently, doctors feel compelled to prescribe broad-spectrum antimicrobials during initial encounters to prevent clinical deterioration. Practical stewardship protocols must acknowledge these follow-up limitations and offer realistic management strategies for patients who cannot undergo scheduled reviews.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Schermuly A et al. Contextualizing a One Health definition of appropriate antimicrobial use. JAC Antimicrob Resist. 2026 Dec undefined. doi: 10.1093/jacamr/dlag240. PMID: 42973459.


2. Indian Council of Medical Research. Guidelines for Antimicrobial Stewardship Program in Healthcare Facilities in India. New Delhi: ICMR; 2022.


3. National Centre for Disease Control. National Action Plan on Antimicrobial Resistance (NAP-AMR) 2.0 (2025–2029). New Delhi: Ministry of Health and Family Welfare, Government of India; 2025.


4. World Health Organization. Global Action Plan on Antimicrobial Resistance. Geneva: World Health Organization; 2015.